Monitoring histological changes in oral mucosa using AgNORs as biomarkers for oxygenic stress in smokers and COPD patients

Journal Title: IOSR Journal of Pharmacy (IOSRPHR) - Year 2015, Vol 5, Issue 4

Abstract

 Background: It is well known that tobacco smoke causes cellular proliferation and chronic obstructive pulmonary disease (COPD), but changes in buccal mucosa cells in smokers and COPD patients remains unknown. Aims: The aim of this study is twofold: (i) to assess the effect of smoking on cellular proliferative activity of buccal mucosa in healthy smokers and in smoking COPD patients (ii) to detect early cellular proliferative activity in buccal mucosa. Our hypothesis is that tobacco smoking induces changes in buccal mucosa cells that we can detect using AgNOR analysis.

Authors and Affiliations

1Galal A. S. Omar ,

Keywords

Related Articles

 Distribution And Daily Activity Of Collared Dove (Streptopelia Decaocto) In And Around Sikar (Rajasthan), India

 Collared Dove is native species of Asia and Europe. It is found in throughout the drier portions of the Indian Union. Collared Dove native to India, Sri Lanka and Myanmar. It is not migratory bird but it is str...

 Seasonal Variation of Circadian Activity of Rat Measured by Circadian Locomotor Modified Cage

 Circadian rhythm variations are related to seasonal photoperiodic variations, which affect animal as well as human physiology and behavior. The present study aimed to evaluate the effect of photoperiodic...

 Candidate Molecules as Tumor Suppressor for Human Uterine Mesenchymal Tumor

 Uterine leiomyosarcoma (Ut-LMS) develops more often in myometrium of the uterine body than in the uterine cervix. The development of gynecologic tumors is often correlated with female hormone secretion; however,...

Download PDF file
  • EP ID EP158479
  • DOI -
  • Views 98
  • Downloads 0

How To Cite

1Galal A. S. Omar, (2015).  Monitoring histological changes in oral mucosa using AgNORs as biomarkers for oxygenic stress in smokers and COPD patients. IOSR Journal of Pharmacy (IOSRPHR), 5(4), 24-29. https://www.europub.co.uk/articles/-A-158479